Drug development startup TheraVida has raised $3.6 million in equity and debt. The Mountain View, Calif. company is looking to raise a total of $6.3 million, according to a filing with the SEC. Founded in 2005, TheraVida is currently researching products for treatment of urological problems. Sanderling Ventures is an investor in the company.